Q4 2020 Holdings
Filed 2021-02-16 | 44 holdings | $859.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $300.2M | 1,800,000 | 34.9% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $265.4M | 902,500 | 30.9% |
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $144.7M | 1,650,000 | 16.8% |
| Acadia Pharmaceuticals Inc(ACAD) | Common | 004225108 | $104.2M | 1,950,000 | 12.1% |
| Black Diamond Therapeutics Inc(BDTX) | Common | 09203E105 | $20.5M | 640,000 | 2.4% |
| Adaptimmune Therapeutics PLC(ADAPY) | Sponsored ADR | 00653A107 | $19.1M | 3,550,000 | 2.2% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $996.1K | 4,535,000 | 0.1% |
| Horizon Therapeutics PLC | Common | G46188101 | $658.4K | 9,000,000 | 0.1% |
| United Therapeutics Corp(UTHR) | Common | 91307C102 | $432.6K | 2,850,000 | 0.1% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $348.0K | 7,500,000 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | Common | 040047607 | $321.9K | 4,190,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | Common | 803607100 | $298.4K | 1,750,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $207.8K | 9,000,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | Common | 00434H108 | $198.3K | 1,550,000 | 0.0% |
| Mersana Therapeutics Inc | Common | 59045L106 | $180.9K | 6,800,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $136.2K | 1,225,000 | 0.0% |
| Kura Oncology Inc(KURA) | Common | 50127T109 | $130.6K | 4,000,000 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | Common | 69353Y103 | $130.5K | 2,350,267 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | Common | 00773U108 | $86.7K | 8,000,000 | 0.0% |
| Trillium Therapeutics Inc | Common | 89620X506 | $85.3K | 5,800,000 | 0.0% |
| Constellation Pharmaceuticals Inc(CNST) | Common | 210373106 | $85.0K | 2,950,000 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | Common | 24344T101 | $74.2K | 1,300,000 | 0.0% |
| Praxis Precision Medicines Inc | Common | 74006W108 | $68.7K | 1,545,495 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $59.1K | 10,300,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | Common | 46583P102 | $50.1K | 7,250,000 | 0.0% |
| Travere Therapeutics Inc(TVTX) | Common | 89422G107 | $49.1K | 1,800,500 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | Common | 75955J402 | $48.9K | 1,525,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $43.1K | 2,800,000 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | Common | 56854Q200 | $39.4K | 3,232,142 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $35.6K | 876,986 | 0.0% |
| Amarin Corp PLC | Sponsored ADR | 023111206 | $29.3K | 6,000,000 | 0.0% |
| Avadel Pharmaceuticals PLC | Sponsored ADR | 05337M104 | $29.2K | 4,365,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | Common | 75943R102 | $20.8K | 500,000 | 0.0% |
| Iteos Therapeutics Inc(5E7) | Common | 46565G104 | $15.6K | 460,000 | 0.0% |
| Therapeutics Acquisition Corp | Common | 88339T103 | $14.0K | 1,000,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | Common | 05370A108 | $13.9K | 545,000 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | Common | 31447P100 | $12.4K | 1,670,000 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | Common | 372427401 | $12.3K | 5,084,184 | 0.0% |
| Mannkind Corp(MNKD) | Common | 56400P706 | $11.0K | 3,500,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | Common | 87164F105 | $10.0K | 450,000 | 0.0% |
| Bctg Acquisition Corp | Common | 05492W103 | $9.2K | 800,000 | 0.0% |
| CUE Biopharma Inc(CUE) | Common | 22978P106 | $5.7K | 452,500 | 0.0% |
| Athenex Inc(ATNXEUR) | Common | 04685N103 | $4.1K | 372,500 | 0.0% |
| Nektar Therapeutics(NKTREUR)Call | Common | 640268108 | $26 | 100,000 | 0.0% |